INSP - Inspire Medical Systems, Inc.
NYSE
->
Healthcare
->
Medical Devices
Golden Valley,
United States
Type: Equity
INSP price evolution
INSP
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $188.03 | $175.42 | $185.54 | $329.9 |
| Short term investments | $251.63 | $265.94 | $274.84 | $134.32 |
| Net receivables | $79.72 | $72.33 | $89.88 | $71.46 |
| Inventory | $59.02 | $48.97 | $33.88 | $26.11 |
| Total current assets | $607.16 | $572.21 | $593.74 | $569.59 |
| Long term investments | $26.34 | $27.8 | $9.14 | $2.96 |
| Property, plant & equipment | $83.89 | $74.53 | $62.65 | $55.33 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $121.23 | $113.63 | $83.07 | $69.9 |
| Total investments | $277.97 | $293.75 | $283.98 | $137.28 |
| Total assets | $728.39 | $685.84 | $676.81 | $639.49 |
| Current liabilities | ||||
| Accounts payable | $33.62 | $43.8 | $38.84 | $40.03 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $65.66 | $72.17 | $78.11 | $70 |
| Long term debt | $24.51 | $24.5 | $24.85 | $25.17 |
| Total noncurrent liabilities | $24.66 | $24.65 | $26.19 | $25.32 |
| Total debt | $24.51 | $24.5 | $24.85 | $25.17 |
| Total liabilities | $90.32 | $96.82 | $104.3 | $95.31 |
| Shareholders' equity | ||||
| Retained earnings | -$345.63 | -$355.43 | -$345.42 | -$360.19 |
| Other shareholder equity | -$0.12 | $0.12 | $0.8 | $0.04 |
| Total shareholder equity | $638.07 | $589.02 | $572.51 | $544.18 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $185.54 | $441.59 | $214.47 | $190.52 |
| Short term investments | $274.84 | $9.82 | $43.84 | |
| Net receivables | $89.88 | $61.23 | $34.18 | $25.06 |
| Inventory | $33.88 | $11.89 | $17.23 | $8.48 |
| Total current assets | $593.74 | $530.03 | $268.54 | $269.87 |
| Long term investments | $9.14 | $9.94 | ||
| Property, plant & equipment | $62.65 | $24.13 | $16.41 | $11.12 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $83.07 | $34.84 | $26.55 | $11.32 |
| Total investments | $283.98 | $9.82 | $9.94 | $43.84 |
| Total assets | $676.81 | $564.88 | $295.08 | $281.19 |
| Current liabilities | ||||
| Accounts payable | $38.84 | $26.85 | $11.66 | $7.21 |
| Deferred revenue | ||||
| Short long term debt | $9.19 | |||
| Total current liabilities | $78.11 | $61.19 | $41.31 | $20.73 |
| Long term debt | $24.85 | $7.54 | $24.59 | $30.63 |
| Total noncurrent liabilities | $26.19 | $7.68 | $24.73 | $30.72 |
| Total debt | $24.85 | $7.54 | $33.78 | $30.63 |
| Total liabilities | $104.3 | $68.87 | $66.04 | $51.44 |
| Shareholders' equity | ||||
| Retained earnings | -$345.42 | -$324.27 | -$279.39 | -$237.35 |
| Other shareholder equity | $0.8 | -$0.09 | -$0.06 | $0.03 |
| Total shareholder equity | $572.51 | $496.01 | $229.05 | $229.75 |
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $195.88 | $164.01 | $192.51 | $153.3 |
| Cost of revenue | $29.84 | $24.76 | $28.05 | $24.38 |
| Gross Profit | $166.04 | $139.25 | $164.45 | $128.92 |
| Operating activities | ||||
| Research & development | $28.86 | $28.85 | $31.05 | $29.14 |
| Selling, general & administrative | $132.08 | $125.62 | $124.11 | $113.25 |
| Total operating expenses | $160.94 | $154.47 | $155.16 | $142.39 |
| Operating income | $5.1 | -$15.22 | $9.3 | -$13.47 |
| Income from continuing operations | ||||
| EBIT | $10.85 | -$9.36 | $15.24 | -$8.2 |
| Income tax expense | $1.05 | $0.65 | $0.48 | $0.34 |
| Interest expense | ||||
| Net income | ||||
| Net income | $9.79 | -$10.01 | $14.76 | -$8.54 |
| Income (for common shares) | $9.79 | -$10.01 | $14.76 | -$8.54 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $624.8 | $407.86 | $233.39 | $115.38 |
| Cost of revenue | $96.58 | $66.11 | $33.28 | $17.62 |
| Gross Profit | $528.22 | $341.74 | $200.12 | $97.76 |
| Operating activities | ||||
| Research & development | $116.54 | $68.64 | $37.35 | $26.09 |
| Selling, general & administrative | $451.96 | $320.69 | $202.62 | $127.87 |
| Total operating expenses | $568.49 | $389.33 | $239.97 | $153.97 |
| Operating income | -$40.27 | -$47.59 | -$39.85 | -$56.21 |
| Income from continuing operations | ||||
| EBIT | -$19.91 | -$42.59 | -$39.84 | -$54.97 |
| Income tax expense | $1.25 | $0.61 | $0.07 | $0.12 |
| Interest expense | $1.68 | $2.13 | $2.12 | |
| Net income | ||||
| Net income | -$21.15 | -$44.88 | -$42.04 | -$57.2 |
| Income (for common shares) | -$21.15 | -$44.88 | -$42.04 | -$57.2 |
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Net income | $9.79 | -$10.01 | $14.76 | -$8.54 |
| Operating activities | ||||
| Depreciation | $1.44 | $1.26 | $1.23 | $1.17 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $32.32 | $26.32 | $22.85 | $19.83 |
| Total cash flows from operations | -$0.08 | $8.86 | $17.27 | $3.64 |
| Investing activities | ||||
| Capital expenditures | -$12.39 | -$11.7 | -$8.03 | -$6.99 |
| Investments | $18.01 | -$7.84 | -$143.69 | -$137.25 |
| Total cash flows from investing | $5.62 | -$19.54 | -$151.72 | -$144.24 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $8.95 | $3.62 | $3.81 | $4.02 |
| Net borrowings | ||||
| Total cash flows from financing | $7.09 | $0.77 | -$10.12 | $3.5 |
| Effect of exchange rate | -$0.01 | -$0.21 | $0.21 | -$0.05 |
| Change in cash and equivalents | $12.62 | -$10.12 | -$144.36 | -$137.15 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$21.15 | -$44.88 | -$42.04 | -$57.2 |
| Operating activities | ||||
| Depreciation | $4.25 | $2.9 | $1.99 | $1.81 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $82.47 | $51.97 | $26.18 | $12.82 |
| Total cash flows from operations | $24.65 | $11.57 | -$20.12 | -$53.05 |
| Investing activities | ||||
| Capital expenditures | -$23.63 | -$9.1 | -$4.67 | -$2.46 |
| Investments | -$271.19 | -$10.5 | $33.81 | $89.08 |
| Total cash flows from investing | -$294.82 | -$19.6 | $29.14 | $86.63 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $31.11 | $259.62 | $14.95 | $134.06 |
| Net borrowings | -$24.5 | |||
| Total cash flows from financing | $13.95 | $235.08 | $14.95 | $134.06 |
| Effect of exchange rate | $0.16 | $0.07 | -$0.02 | $0.01 |
| Change in cash and equivalents | -$256.06 | $227.13 | $23.95 | $167.66 |
News
Fundamentals
| Market cap | $5.87B |
|---|---|
| Enterprise value | $5.70B |
| Shares outstanding | 29.81M |
| Revenue | $705.71M |
|---|---|
| EBITDA | $13.63M |
| EBIT | $8.53M |
| Net Income | $6.01M |
| Revenue Q/Q | 29.65% |
| Revenue Y/Y | 34.14% |
| P/E ratio | 976.22 |
|---|---|
| EV/Sales | 8.08 |
| EV/EBITDA | 418.50 |
| EV/EBIT | 668.68 |
| P/S ratio | 8.32 |
| P/B ratio | 9.19 |
| Book/Share | 21.41 |
| Cash/Share | 6.31 |
| EPS | $0.20 |
|---|---|
| ROA | 0.88% |
| ROE | 1.03% |
| Debt/Equity | 0.18 |
|---|---|
| Net debt/EBITDA | -7.17 |
| Current ratio | 9.25 |
| Quick ratio | 8.35 |